Grant: Discovery Grants Program - Individual
University of Toronto
$35,000.00
Novel monomer and polymer synthesis with antimicrobial function and their reaction with enzymes
FY 2017-18
Summary
Acquired bacterial infections affect nearly 5% of all hospitalized patients and are transmitted via medical devices. Bacteria have the ability to adhere to biomaterials used to fabricate such devices and promote the formation of biofilms. This is an on-going challenge as traditional systematic treatment by antibiotics is often insufficient to overcome the complex organization of the bacterial biofilms. With an increasing aging population in Canada and other countries, the need for polymeric biomaterials with pro-biotic and/or microbial resistant function along with healing character in some instances, is needed to better address microbial challenges. The hypothesis of this grant is that antimicrobial containing monomers and bacterial resistant monomers, and their polymers, generated from synthetic pathways will yield functional biomaterials. There are three principal objectives: 1) To study the resistance of novel urethane-fluorinated monomers generated previously in the laboratory to saliva derived enzymes, and to produce polymers with these monomers, that are optimized for physical performance properties, and resistance to enzyme/bacterial interactions. 2) To incorporate chemistry into novel antimicrobial monomers that will yield polymers with practical physical properties and resistance to bacterial biofilm formation. 3) To generate new periodontal tissues to repair tissue around teeth using a synthetic degradable hydrogel material which facilitates the growth of connective tissue from the host fibroblast cells, and new blood vessels from the host endothelial cells. The findings from all 3 of the above objectives will combine to yield innovative new chemistries and a greater understanding of the influence of monomer chemical structure on the physical, biochemical and biological outcomes of biomaterials, conceived for use where bacteria containing environments yield significant challenges towards achieving a successful clinical/commercial impact for products associated with Canada's healthcare industry. This research is training HQP in the biomedical engineering field (a field with 72% job growth rate- US Bureau of labor statistics).
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
360520-2013
Name nom
Santerre, Paul
Department département
Dentistry, Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2013
Award amount
35000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
5
Nb partie
5
Application title
Novel monomer and polymer synthesis with antimicrobial function and their reaction with enzymes
Keyword
NSERC
Application summary
Acquired bacterial infections affect nearly 5% of all hospitalized patients and are transmitted via medical devices. Bacteria have the ability to adhere to biomaterials used to fabricate such devices and promote the formation of biofilms. This is an on-going challenge as traditional systematic treatment by antibiotics is often insufficient to overcome the complex organization of the bacterial biofilms. With an increasing aging population in Canada and other countries, the need for polymeric biomaterials with pro-biotic and/or microbial resistant function along with healing character in some instances, is needed to better address microbial challenges. The hypothesis of this grant is that antimicrobial containing monomers and bacterial resistant monomers, and their polymers, generated from synthetic pathways will yield functional biomaterials. There are three principal objectives: 1) To study the resistance of novel urethane-fluorinated monomers generated previously in the laboratory to saliva derived enzymes, and to produce polymers with these monomers, that are optimized for physical performance properties, and resistance to enzyme/bacterial interactions. 2) To incorporate chemistry into novel antimicrobial monomers that will yield polymers with practical physical properties and resistance to bacterial biofilm formation. 3) To generate new periodontal tissues to repair tissue around teeth using a synthetic degradable hydrogel material which facilitates the growth of connective tissue from the host fibroblast cells, and new blood vessels from the host endothelial cells. The findings from all 3 of the above objectives will combine to yield innovative new chemistries and a greater understanding of the influence of monomer chemical structure on the physical, biochemical and biological outcomes of biomaterials, conceived for use where bacteria containing environments yield significant challenges towards achieving a successful clinical/commercial impact for products associated with Canada's healthcare industry. This research is training HQP in the biomedical engineering field (a field with 72% job growth rate- US Bureau of labor statistics).